Jeff Jasper

Jeff Jasper is currently working as the Oncology R&D Product Director at Myriad Genetics since December 2021. Prior to this, Jeff held positions at Q² Solutions, Duke University Health System, Sorenson Genomics, and Seare Biomatrix Systems, gaining experience in areas such as genomic portfolio management, bioinformatics, and research. Jeff holds a Doctor of Philosophy (PhD) in Pharmacology and Cancer Biology from Duke University, as well as a BS in Biochemistry from the University of Utah.